Wednesday, June 22, 2016
- 12:00pm-1:30pm
-
Tracking Parkinson’s disease over 2-6 years with MRI
Parkinson's disease: Neuroimaging and neurophysiology · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Tractographic patterns of effective pallidal DBS in DYT-6 Dystonia: A case study
Neuroimaging (non-PD) · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Tractography study of individuals with mutation for Huntington’s disease in symptomatic and pre-symptomatic phases
Huntington's disease · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Transcranial sonography and cognitive dysfunction in Parkinson’s disease
Parkinson's disease: Cognition · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Transcranial sonography of the substantia nigra and its correlation with iron metabolism and c-reactive protein in Parkinson’s disease
Parkinson's disease: Neuroimaging and neurophysiology · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Transcranial static magnetic field stimulation (tSMS) decreases motor cortex excitability in Parkinson’s disease OFF but not ON medication
Parkinson's disease: Neuroimaging and neurophysiology · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Transient hemiballismus in a fast jet pilot
Phenomenology and clinical assessment of movement disorders · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Treatment and diagnosis with the use of neuropsychological scale in patients with posttraumatic subcortical Parkinsonian dementia
Parkinson's disease: Cognition · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Treatment with the use of the PD-specific scales for patients suffering from subcortical Parkinsonian dementia
Parkinson's disease: Cognition · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Ultra high field magnetic resonance imaging of nigrosome 1 is a biomarker of new onset and premotor Parkinson’s disease
Parkinson's disease: Neuroimaging and neurophysiology · Exhibit Hall located in Hall B, Level 2